Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Transpl Infect Dis. 2019 Dec 30;22(2):e13233. doi: 10.1111/tid.13233

Table 2:

CMV Outcomes at 1 Year Follow-Up

Ganciclovir (n=52) Foscarnet (n=12) P value
Recurrence of CMV Viremia 9 (16%) 4 (33%) 0.24
CMV Disease 2 (4%) 0 (0%) 1.00
Death 16 (28%) 5 (42%) 0.50
Death with Positive CMV Viremia 7 (13%) 1 (8%) 1.00